Answer:
Longer
Step-by-step explanation:
Along with being a nonopioid pain relief medication, aspirin has two other major known properties. The first is as an antipyretic, meaning it can be used for fever relief. The second is as an antiplatelet medication, meaning it decreases the ability of platelets to aggregate, or to cluster. Platelets (also known as thrombocytes) are the clot-forming products floating in the bloodstream that, when clustered together, patch wounds involving trauma to vessels of the circulatory system. If this ability to cluster together is inhibited, it will not cause a full cessation of one's coagulation process -- this is the job of anticoagulant medications like heparin and warfarin -- but it will prolong the time it takes for the process to yield.
Further, patients that are anemic have less red blood cells and possibly a decreased production of platelets, as can be the case with the condition called thrombocytopenia. An inadequate amount of platelets can also affect the ability to form clots, meaning they will take longer to form.
Therefore, clotting time is longer when the patient is undergoing aspirin pharmacotherapy and or is documented anemic.